181 related articles for article (PubMed ID: 19217288)
1. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of potent antitumor and antiviral benzofuran derivatives.
Galal SA; Abd El-All AS; Abdallah MM; El-Diwani HI
Bioorg Med Chem Lett; 2009 May; 19(9):2420-8. PubMed ID: 19345581
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines.
Wlodarczyk N; Gilleron P; Millet R; Houssin R; Goossens JF; Lemoine A; Pommery N; Wei MX; Hénichart JP
Oncol Res; 2005; 16(3):107-18. PubMed ID: 16925112
[TBL] [Abstract][Full Text] [Related]
4. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
Lombardo LJ; Camuso A; Clark J; Fager K; Gullo-Brown J; Hunt JT; Inigo I; Kan D; Koplowitz B; Lee F; McGlinchey K; Qian L; Ricca C; Rovnyak G; Traeger S; Tokarski J; Williams DK; Wu LI; Zhao Y; Manne V; Bhide RS
Bioorg Med Chem Lett; 2005 Apr; 15(7):1895-9. PubMed ID: 15780629
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.
Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P
Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109
[TBL] [Abstract][Full Text] [Related]
7. Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra series.
Angibaud P; Mevellec L; Meyer C; Bourdrez X; Lezouret P; Pilatte I; Poncelet V; Roux B; Merillon S; End DW; Van Dun J; Wouters W; Venet M
Eur J Med Chem; 2007 May; 42(5):702-14. PubMed ID: 17316920
[TBL] [Abstract][Full Text] [Related]
8. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
[TBL] [Abstract][Full Text] [Related]
11. 4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA.
Angibaud P; Saha AK; Bourdrez X; End DW; Freyne E; Lezouret P; Mannens G; Mevellec L; Meyer C; Pilatte I; Poncelet V; Roux B; Smets G; Van Dun J; Venet M; Wouters W
Bioorg Med Chem Lett; 2003 Dec; 13(24):4361-4. PubMed ID: 14643326
[TBL] [Abstract][Full Text] [Related]
12. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
[TBL] [Abstract][Full Text] [Related]
13. 5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors.
Angibaud P; Bourdrez X; Devine A; End DW; Freyne E; Ligny Y; Muller P; Mannens G; Pilatte I; Poncelet V; Skrzat S; Smets G; Van Dun J; Van Remoortere P; Venet M; Wouters W
Bioorg Med Chem Lett; 2003 May; 13(9):1543-7. PubMed ID: 12699751
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of analogues of the anti-tumor alkaloid naamidine A.
Aberle N; Catimel J; Nice EC; Watson KG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3741-4. PubMed ID: 17462892
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
18. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
19. Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Esposito A; Novellino E; Lavecchia A
J Med Chem; 2008 Dec; 51(24):8148-57. PubMed ID: 19053767
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.
Haddach M; Pierre F; Regan CF; Borsan C; Michaux J; Stefan E; Kerdoncuff P; Schwaebe MK; Chua PC; Siddiqui-Jain A; Macalino D; Drygin D; O'Brien SE; Rice WG; Ryckman DM
Bioorg Med Chem Lett; 2012 Jan; 22(1):45-8. PubMed ID: 22169261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
